Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy.
Montagnese S, Lauridsen M, Vilstrup H, Zarantonello L, Lakner G, Fitilev S, Zupanets I, Kozlova I, Bunkova E, Tomasiewicz K, Berglund JE, Rorsman F, Hagström H, Kechagias S, Ocklind CE, Mauney J, Thunarf F, Mokhatarani M, Bäckström T, Doverskog M, Lins LE, Månsson M, Samuelson P, Nilsson D, Schalling M, Johansson M, Arlander E, Scharschmidt BF. Montagnese S, et al. Among authors: kechagias s. J Hepatol. 2021 Jul;75(1):98-107. doi: 10.1016/j.jhep.2021.03.012. Epub 2021 Apr 21. J Hepatol. 2021. PMID: 33894327 Free article. Clinical Trial.
Reply.
Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stal P, Kechagias S, Hultcrantz R. Ekstedt M, et al. Among authors: kechagias s. Hepatology. 2016 Jul;64(1):310-1. doi: 10.1002/hep.28314. Epub 2015 Dec 23. Hepatology. 2016. PMID: 26517017 No abstract available.
SAF score and mortality in NAFLD after up to 41 years of follow-up.
Hagström H, Nasr P, Ekstedt M, Kechagias S, Stål P, Bedossa P, Hultcrantz R. Hagström H, et al. Among authors: kechagias s. Scand J Gastroenterol. 2017 Jan;52(1):87-91. doi: 10.1080/00365521.2016.1230779. Epub 2016 Sep 10. Scand J Gastroenterol. 2017. PMID: 27616339 Free article.
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
Hagström H, Nasr P, Ekstedt M, Kechagias S, Önnerhag K, Nilsson E, Rorsman F, Sheikhi R, Marschall HU, Hultcrantz R, Stål P. Hagström H, et al. Among authors: kechagias s. Scand J Gastroenterol. 2017 Feb;52(2):159-165. doi: 10.1080/00365521.2016.1239759. Epub 2016 Oct 6. Scand J Gastroenterol. 2017. PMID: 27650916 Free article.
Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.
Lykiardopoulos B, Hagström H, Fredrikson M, Ignatova S, Stål P, Hultcrantz R, Ekstedt M, Kechagias S. Lykiardopoulos B, et al. Among authors: kechagias s. PLoS One. 2016 Dec 9;11(12):e0167776. doi: 10.1371/journal.pone.0167776. eCollection 2016. PLoS One. 2016. PMID: 27936091 Free PMC article.
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VW, Kechagias S, Hultcrantz R, Loomba R. Dulai PS, et al. Among authors: kechagias s. Hepatology. 2017 May;65(5):1557-1565. doi: 10.1002/hep.29085. Epub 2017 Mar 31. Hepatology. 2017. PMID: 28130788 Free PMC article. Review.
Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis.
Danielsson Borssén Å, Marschall HU, Bergquist A, Rorsman F, Weiland O, Kechagias S, Nyhlin N, Verbaan H, Nilsson E, Werner M. Danielsson Borssén Å, et al. Among authors: kechagias s. Scand J Gastroenterol. 2017 Sep;52(9):1022-1028. doi: 10.1080/00365521.2017.1335772. Epub 2017 May 31. Scand J Gastroenterol. 2017. PMID: 28562110
119 results